whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients

February 2011

Experts are debating whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients.

Up to 25% of patients don't respond well to clopidogrel's antiplatelet effects...and are at higher risk for a cardiac event.

So some prescribers order platelet function tests to identify patients who have high platelet activity despite clopidogrel therapy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote